Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

@inproceedings{Wiemer2017ErratumTT,
  title={Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up},
  author={Marcus Wiemer and Sinisa M. Stojkovic and Alexander Samol and Zisis Dimitriadis and Juan Miguel Ru{\'i}z-Nodar and Ralf Birkemeyer and Jacques Mons{\'e}gu and G{\'e}rard Finet and David J R Hildick-Smith and Damras Tresukosol and Enrique Garcia Novo and Jacques J. Koolen and Emanuele Barbato and Gian Battista Danzi},
  booktitle={Cardiovascular diabetology},
  year={2017}
}
OBJECTIVE To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years. BACKGROUND After percutaneous coronary intervention patients with diabetes mellitus are under higher risk of death, restenosis and stent thrombosis (ST) compared to non-diabetic patients. METHODS In 126 centers worldwide 3067 patients were enrolled in the NOBORI 2… CONTINUE READING